Skip to content
Lower risk Medical device recall · FDA · Published April 15, 2025

Siemens Atellica Homocysteine Calibrator Recall: Inaccurate Test Results Risk

Siemens recalls Atellica IM Homocysteine Calibrator (2 Pack) due to unstable calibrators causing inaccurate test results. Affected lots may give false high readings. Contact Siemens for details.

🇺🇸 FDA recall #Z-1821-2025Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.333 Coney St · East Walpole, MA 02032-1516
✎ GovInfoNow plain-language explainer

What happened, in plain English

Siemens is recalling Atellica IM Homocysteine Calibrator (2 Pack) because certain lots are unstable and produce inaccurate test results. This could lead to false high readings in homocysteine tests, potentially affecting medical decisions. Read more at govinfonow.com/recall/52452-siemens-atellica-homocysteine-calibrator-recall-inaccurate-test-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/52452-siemens-atellica-homocysteine-calibrator-recall-inaccurate-test-results-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1821-2025

Cite this page

“Siemens Atellica Homocysteine Calibrator Recall: Inaccurate Test Results Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52452-siemens-atellica-homocysteine-calibrator-recall-inaccurate-test-results-risk. Based on FDA recall #Z-1821-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1821-2025%22&limit=1).

Why it’s dangerous

The calibrator may become unstable over time, causing test results to be higher than they should be. This increased positive bias could lead to false high homocysteine readings, which might affect medical decisions if not corrected.

Who’s affected

Lab users who purchased the Atellica IM Homocysteine Calibrator (2 Pack) with Siemens Material Number 10995498 are affected. Those using the calibrator for homocysteine testing in medical labs are most at risk.

How to tell if you have this one

Check for Siemens Material Number 10995498 on the calibrator packaging. Look for lot numbers 86236A74, 44206A75, 25675A77, 44505A78, or 52364A79. The recall was updated on May 8, 2026.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KY, MA, MD, ME, MI, MO, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, TX, UT, VA, VT, WI, WY and the countries of Austria, Belgium, Croatia, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Egypt, Finland, France, Georgia, Germany, Greece, Hungary, Iran, Ireland, Israel, Italy, Jordan, Kuwait, Latvia, Lithuania, Nepal, Netherlands, Norway, Pakistan, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, Turkey, Turkmenistan, U.A.E., United¿Kingdom, Vatikan City, Zaire.
Recall numberProduct, codes & lotsQuantity
Z-1821-2025Atellica IM Homocysteine Calibrator (2 Pack). Siemens Material Number: 10995498; Siemens Material Number: 10995498. UDI-DI: 00630414598253 Kit lot numbers: 86236A74, 44206A75. ***Updated 5/8/26*** Additional Lots 25675A77, 44505A78, 52364A79.2,212 packs (4,424 units) - 448 packs US, 1,764 packs OUS
Z-1822-2025ADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376.; Siemens Material Number: 10310376. UDI-DI 00630414468198 Kit lot numbers: 86237A74, 44207A75. ***Updated 5/8/26*** Additional lots 25674A77 52363A791,072 packs (2,144 units) - 156 packs US, 916 packs OUS
Based on the official FDA remedy

What to do — step by step

  1. Check Calibrator Lot Number

    Look for lot numbers 86236A74, 44206A75, 25675A77, 44505A78, or 52364A79 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 37 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: nationwideWAIdaho: nationwideIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: nationwideKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, IL, IN, KY, MA, MD, ME, MI, MO, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, TX, UT, VA, VT, WI, WY and the countries…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, Texas, Utah, Vermont, Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Apr 15, 202512. FDA classified it Class II: May 27, 202523. Published in FDA’s Enforcement Report: Jun 4, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1821-2025 (April 15, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1821-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA